Copyright Reports & Markets. All rights reserved.

Global Tiapride Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Tiapride Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Powder
    • 1.3.3 Liquid
    • 1.3.4 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Tiapride Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Alcoholism
    • 1.4.3 Agitation and Aggression
    • 1.4.4 Movement Disorders
  • 1.5 Global Tiapride Market Size & Forecast
    • 1.5.1 Global Tiapride Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Tiapride Sales Quantity (2020-2031)
    • 1.5.3 Global Tiapride Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Toronto Research Chemical
    • 2.1.1 Toronto Research Chemical Details
    • 2.1.2 Toronto Research Chemical Major Business
    • 2.1.3 Toronto Research Chemical Tiapride Product and Services
    • 2.1.4 Toronto Research Chemical Tiapride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Toronto Research Chemical Recent Developments/Updates
  • 2.2 ChemScence
    • 2.2.1 ChemScence Details
    • 2.2.2 ChemScence Major Business
    • 2.2.3 ChemScence Tiapride Product and Services
    • 2.2.4 ChemScence Tiapride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 ChemScence Recent Developments/Updates
  • 2.3 JSN Chemical
    • 2.3.1 JSN Chemical Details
    • 2.3.2 JSN Chemical Major Business
    • 2.3.3 JSN Chemical Tiapride Product and Services
    • 2.3.4 JSN Chemical Tiapride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 JSN Chemical Recent Developments/Updates
  • 2.4 Century Pharmaceuticals
    • 2.4.1 Century Pharmaceuticals Details
    • 2.4.2 Century Pharmaceuticals Major Business
    • 2.4.3 Century Pharmaceuticals Tiapride Product and Services
    • 2.4.4 Century Pharmaceuticals Tiapride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Century Pharmaceuticals Recent Developments/Updates
  • 2.5 Henan Tianfu Chemical
    • 2.5.1 Henan Tianfu Chemical Details
    • 2.5.2 Henan Tianfu Chemical Major Business
    • 2.5.3 Henan Tianfu Chemical Tiapride Product and Services
    • 2.5.4 Henan Tianfu Chemical Tiapride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Henan Tianfu Chemical Recent Developments/Updates
  • 2.6 Huvepharma Italia Srl
    • 2.6.1 Huvepharma Italia Srl Details
    • 2.6.2 Huvepharma Italia Srl Major Business
    • 2.6.3 Huvepharma Italia Srl Tiapride Product and Services
    • 2.6.4 Huvepharma Italia Srl Tiapride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Huvepharma Italia Srl Recent Developments/Updates
  • 2.7 Bettering Biotech
    • 2.7.1 Bettering Biotech Details
    • 2.7.2 Bettering Biotech Major Business
    • 2.7.3 Bettering Biotech Tiapride Product and Services
    • 2.7.4 Bettering Biotech Tiapride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Bettering Biotech Recent Developments/Updates
  • 2.8 Lebsa
    • 2.8.1 Lebsa Details
    • 2.8.2 Lebsa Major Business
    • 2.8.3 Lebsa Tiapride Product and Services
    • 2.8.4 Lebsa Tiapride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Lebsa Recent Developments/Updates
  • 2.9 Sanofi
    • 2.9.1 Sanofi Details
    • 2.9.2 Sanofi Major Business
    • 2.9.3 Sanofi Tiapride Product and Services
    • 2.9.4 Sanofi Tiapride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Sanofi Recent Developments/Updates
  • 2.10 Daito
    • 2.10.1 Daito Details
    • 2.10.2 Daito Major Business
    • 2.10.3 Daito Tiapride Product and Services
    • 2.10.4 Daito Tiapride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Daito Recent Developments/Updates
  • 2.11 Finorga SA
    • 2.11.1 Finorga SA Details
    • 2.11.2 Finorga SA Major Business
    • 2.11.3 Finorga SA Tiapride Product and Services
    • 2.11.4 Finorga SA Tiapride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Finorga SA Recent Developments/Updates
  • 2.12 Huvepharma
    • 2.12.1 Huvepharma Details
    • 2.12.2 Huvepharma Major Business
    • 2.12.3 Huvepharma Tiapride Product and Services
    • 2.12.4 Huvepharma Tiapride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Huvepharma Recent Developments/Updates
  • 2.13 ICROM
    • 2.13.1 ICROM Details
    • 2.13.2 ICROM Major Business
    • 2.13.3 ICROM Tiapride Product and Services
    • 2.13.4 ICROM Tiapride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 ICROM Recent Developments/Updates

3 Competitive Environment: Tiapride by Manufacturer

  • 3.1 Global Tiapride Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Tiapride Revenue by Manufacturer (2020-2025)
  • 3.3 Global Tiapride Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Tiapride by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Tiapride Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Tiapride Manufacturer Market Share in 2024
  • 3.5 Tiapride Market: Overall Company Footprint Analysis
    • 3.5.1 Tiapride Market: Region Footprint
    • 3.5.2 Tiapride Market: Company Product Type Footprint
    • 3.5.3 Tiapride Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Tiapride Market Size by Region
    • 4.1.1 Global Tiapride Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Tiapride Consumption Value by Region (2020-2031)
    • 4.1.3 Global Tiapride Average Price by Region (2020-2031)
  • 4.2 North America Tiapride Consumption Value (2020-2031)
  • 4.3 Europe Tiapride Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Tiapride Consumption Value (2020-2031)
  • 4.5 South America Tiapride Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Tiapride Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Tiapride Sales Quantity by Type (2020-2031)
  • 5.2 Global Tiapride Consumption Value by Type (2020-2031)
  • 5.3 Global Tiapride Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Tiapride Sales Quantity by Application (2020-2031)
  • 6.2 Global Tiapride Consumption Value by Application (2020-2031)
  • 6.3 Global Tiapride Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Tiapride Sales Quantity by Type (2020-2031)
  • 7.2 North America Tiapride Sales Quantity by Application (2020-2031)
  • 7.3 North America Tiapride Market Size by Country
    • 7.3.1 North America Tiapride Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Tiapride Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Tiapride Sales Quantity by Type (2020-2031)
  • 8.2 Europe Tiapride Sales Quantity by Application (2020-2031)
  • 8.3 Europe Tiapride Market Size by Country
    • 8.3.1 Europe Tiapride Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Tiapride Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Tiapride Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Tiapride Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Tiapride Market Size by Region
    • 9.3.1 Asia-Pacific Tiapride Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Tiapride Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Tiapride Sales Quantity by Type (2020-2031)
  • 10.2 South America Tiapride Sales Quantity by Application (2020-2031)
  • 10.3 South America Tiapride Market Size by Country
    • 10.3.1 South America Tiapride Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Tiapride Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Tiapride Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Tiapride Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Tiapride Market Size by Country
    • 11.3.1 Middle East & Africa Tiapride Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Tiapride Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Tiapride Market Drivers
  • 12.2 Tiapride Market Restraints
  • 12.3 Tiapride Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Tiapride and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Tiapride
  • 13.3 Tiapride Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Tiapride Typical Distributors
  • 14.3 Tiapride Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Tiapride market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
    Tiapride is a compound that selectively blocks D2 and D3 dopamine receptors in the brain. It is often used to treat a variety of neurological and psychiatric disorders.
    This report is a detailed and comprehensive analysis for global Tiapride market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Tiapride market size and forecasts, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2020-2031
    Global Tiapride market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2020-2031
    Global Tiapride market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2020-2031
    Global Tiapride market shares of main players, shipments in revenue ($ Million), sales quantity (K MT), and ASP (USD/MT), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Tiapride
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Tiapride market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Toronto Research Chemical, ChemScence, JSN Chemical, Century Pharmaceuticals, Henan Tianfu Chemical, Huvepharma Italia Srl, Bettering Biotech, Lebsa, Sanofi, Daito, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Tiapride market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Powder
    Liquid
    Other
    Market segment by Application
    Alcoholism
    Agitation and Aggression
    Movement Disorders
    Major players covered
    Toronto Research Chemical
    ChemScence
    JSN Chemical
    Century Pharmaceuticals
    Henan Tianfu Chemical
    Huvepharma Italia Srl
    Bettering Biotech
    Lebsa
    Sanofi
    Daito
    Finorga SA
    Huvepharma
    ICROM
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Tiapride product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Tiapride, with price, sales quantity, revenue, and global market share of Tiapride from 2020 to 2025.
    Chapter 3, the Tiapride competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Tiapride breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Tiapride market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Tiapride.
    Chapter 14 and 15, to describe Tiapride sales channel, distributors, customers, research findings and conclusion.

    Buy now